Capability of hypertonic saline cough provocation test to predict the response to inhaled corticosteroids in chronic cough: A prospective, open-label study

Cough

Volumn 9, Issue 1, 2013, Pages

  Koskela, Heikki O ^a   Purokivi, Minna K ^a  

^a KUOPIO UNIVERSITY HOSPITAL   (Finland)

Author keywords

Airway hyperresponsiveness; Chronic cough; Cough provocation tests; Inhaled corticosteroids; Nitric oxide

Indexed keywords

BUDESONIDE; CORTICOSTEROID; HISTAMINE; NITRIC OXIDE; SODIUM CHLORIDE;

ADULT; ARTICLE; CLINICAL ARTICLE; COUGHING; DISEASE ASSOCIATION; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; IMMUNE RESPONSE; MALE; OPEN STUDY; PEAK EXPIRATORY FLOW; PROSPECTIVE STUDY; PROVOCATION TEST; QUESTIONNAIRE; SCORING SYSTEM; SPIROMETRY; TREATMENT RESPONSE;

EID: 84877842785     PISSN: None     EISSN: 17459974     Source Type: Journal    
DOI: 10.1186/1745-9974-9-15     Document Type: Article

References (30)

1. Morice AH, McGarvey L, Pavord I. Recommendations for the management of cough in adults. Thorax 2006, 61:i1-i24. 10.1136/thx.2006.065144, 2080754, 16936230.
2. Morice AH, Fontana GA, Belvisi MG, Birring SS, Chung KF, Dicpinigaitis PV, Kastelik JA, McGarvey LP, Smith JA, Tatar M, Widdicombe J. Ers guidelines on the assessment of cough. Eur Respir J 2007, 29:1256-1276. 10.1183/09031936.00101006, 17540788.
3. Irwin RS, Baumann MH, Bolser DC, Boulet LP, Braman SS, Brightling CE, Brown KK, Canning BJ, Chang AB, Dicpinigaitis PV, Eccles R, Glomb WB, Goldstein LB, Graham LM, Hargreave FE, Kvale PA, Lewis SZ, McCool FD, McCrory DC, Prakash UB, Pratter MR, Rosen MJ, Schulman E, Shannon JJ, Smith Hammond C, Tarlo SM. Diagnosis and management of cough executive summary: Accp evidence-based clinical practice guidelines. Chest 2006, 129:1S-23S. 10.1378/chest.129.1_suppl.1S, 3345522, 16428686.
4. Pizzichini MM, Pizzichini E, Parameswaran K, Clelland L, Efthimiadis A, Dolovich J, Hargreave FE. Nonasthmatic chronic cough: no effect of treatment with an inhaled corticosteroid in patients without sputum eosinophilia. Can Respir J 1999, 6:323-330.
5. Chaudhuri R, McMahon AD, Thomson LJ, MacLeod KJ, McSharry CP, Livingston E, McKay A, Thomson NC. Effect of inhaled corticosteroids on symptom severity and sputum mediator levels in chronic persistent cough. J Allergy Clin Immunol 2004, 113:1063-1070. 10.1016/j.jaci.2004.03.019, 15208586.
6. Hahn PY, Morgenthaler TY, Lim KG. Use of exhaled nitric oxide in predicting response to inhaled corticosteroids for chronic cough. Mayo Clin Proc 2007, 82:1350-1355. 10.4065/82.11.1350, 17976354.
7. Prieto L, Ferrer A, Ponce S, Palop J, Marin J. Exhaled nitric oxide measurement is not useful for predicting the response to inhaled corticosteroids in subjects with chronic cough. Chest 2009, 136:816-822. 10.1378/chest.08-2942, 19411296.
8. Undem BJ, Carr MJ, Kollarik M. Physiology and plasticity of putative cough fibres in the guinea pig. Pulm Pharmacol Ther 2002, 15:193-198. 10.1006/pupt.2002.0362, 12099763.
9. Lalloo UG, Fox AJ, Belvisi MG, Chung KF, Barnes PJ. Capsazepine inhibits cough induced by capsaicin and citric acid but not by hypertonic saline in guinea pigs. J Appl Physiol 1995, 79:1082-1087.
10. Koskela H, Purokivi M, Nieminen R, Moilanen E. The cough receptor trpv1 agonists 15(s)-hete and ltb4 in the cough response to hypertonicity. Inflamm Allergy Drug Targets 2012, 11:102-108. 10.2174/187152812800392814, 22280233.
11. Koskela HO, Hyvarinen L, Brannan JD, Chan HK, Anderson SD. Coughing during mannitol challenge is associated with asthma. Chest 2004, 125:1985-1992. 10.1378/chest.125.6.1985, 15189912.
12. Koskela HO, Kontra KM, Purokivi MK, Randell JT. Interpretation of cough provoked by airway challenges. Chest 2005, 128:3329-3335. 10.1378/chest.128.5.3329, 16304280.
13. Koskela HO, Purokivi MK, Kontra KM, Taivainen AH, Tukiainen HO. Hypertonic saline cough provocation test with salbutamol pre-treatment: Evidence for sensorineural dysfunction in asthma. Clin Exp Allergy 2008, 38:1100-1107. 10.1111/j.1365-2222.2008.02996.x, 18462452.
14. Purokivi M, Koskela HO, Koistinen T, Magga J, Peuhkurinen K, Kiviniemi V, Kontra KM. Utility of cough response during hypertonic histamine challenge in diagnosing asthma. Respir Med 2008, 102:1379-1384. 10.1016/j.rmed.2008.05.006, 18640018.
15. Purokivi M, Koskela H, Brannan JD, Kontra K. Cough response to isocapnic hyperpnoea of dry air and hypertonic saline are interrelated. Cough 2011, 7:8. 10.1186/1745-9974-7-8, 3205007, 21999754.
16. Purokivi M, Koskela H, Kontra K. Determinants of asthma control and quality of life in stable asthma: Evaluation of two new cough provocation tests. Clin Respir J 2012, epub ahead print.
17. Dettmar PW, Strugala V, Fathi H, Dettmar HJ, Wright C, Morice AH. The online cough clinic: developing guideline-based diagnosis and advice. Eur Respir J 2009, 34:819-824. 10.1183/09031936.00126908, 19324957.
18. Sovijarvi AR, Malmberg LP, Reinikainen K, Rytila P, Poppius H. A rapid dosimetric method with controlled tidal breathing for histamine challenge. Repeatability and distribution of bronchial reactivity in a clinical material. Chest 1993, 104:164-170. 10.1378/chest.104.1.164, 8325062.
19. Birring SS, Prudon B, Carr AJ, Singh SJ, Morgan MD, Pavord ID. Development of a symptom specific health status measure for patients with chronic cough: Leicester cough questionnaire (LCQ). Thorax 2003, 58:339-343. 10.1136/thorax.58.4.339, 1746649, 12668799.
20. American Thoracic Society and the European Respiratory Society Ats/ers recommendations for standardized procedures for the online and offline measurement of exhaled lower respiratory nitric oxide and nasal nitric oxide, 2005. Am J Respir Crit Care Med 2005, 171:912-930. American Thoracic Society and the European Respiratory Society.
21. Raj AA, Pavord DI, Birring SS. Clinical cough iv: what is the minimal important difference for the Leicester cough questionnaire?. Pharmacology and therapeutics of cough 2009, 311-320. Heidelberg: Springer, Chung KF, Widdicombe JG.
22. Grossman J. One airway, one disease. Chest 1997, 111:11S-16S. 10.1378/chest.111.2_Supplement.11S, 9042022.
23. Camargos P, Ibiapina C, Lasmar L, Cruz AA. Obtaining concomitant control of allergic rhinitis and asthma with a nasally inhaled corticosteroid. Allergy 2007, 62:310-316. 10.1111/j.1398-9995.2007.01241.x, 17298349.
24. Kharitonov SA, Yates DH, Barnes PJ. Inhaled glucocorticoids decrease nitric oxide in exhaled air of asthmatic patients. Am J Respir Crit Care Med 1996, 153:454-457. 10.1164/ajrccm.153.1.8542158, 8542158.
25. O'Connell F, Thomas VE, Pride NB, Fuller RW. Capsaicin cough sensitivity decreases with successful treatment of chronic cough. Am J Respir Crit Care Med 1994, 150:374-380. 10.1164/ajrccm.150.2.8049818, 8049818.
26. Auffarth B, Postma DS, de Monchy JG, van der Mark TW, Boorsma M, Koeter GH. Effects of inhaled budesonide on spirometric values, reversibility, airway responsiveness, and cough threshold in smokers with chronic obstructive lung disease. Thorax 1991, 46:372-377. 10.1136/thx.46.5.372, 1020969, 2068695.
27. Di Franco A, Dente FL, Giannini D, Vagaggini B, Conti I, Macchioni P, Scuotri L, Taccola M, Bacci E, Paggiaro PL. Effects of inhaled corticosteroids on cough threshold in patients with bronchial asthma. Pulm Pharmacol Ther 2001, 14:35-40. 10.1006/pupt.2000.0264, 11162417.
28. Fujimura M, Hara J, Myou S. Change in bronchial responsiveness and cough reflex sensitivity in patients with cough variant asthma: effect of inhaled corticosteroids. Cough 2005, 1:5. 10.1186/1745-9974-1-5, 1277007, 16270932.
29. Nasra J, Belvisi MG. Modulation of sensory nerve function and the cough reflex: understanding disease pathogenesis. Pharmacol Ther 2009, 124:354-375. 10.1016/j.pharmthera.2009.09.006, 19818366.
30. Koskela HO, Purokivi MK, Nieminen RM, Moilanen E. Asthmatic cough and airway oxidative stress. Respir Physiol Neurobiol 2012, 181:346-350. 10.1016/j.resp.2012.04.006, 22546340.